Massachusetts Financial Services
TERN

Massachusetts Financial Services’s Terns Pharmaceuticals TERN Stock Holding History

Massachusetts Financial Services’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,902
Closed -$575K – 1059
2026
Q1 		$575K Buy
+10,902
New +$448K ﹤0.01% 886

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Massachusetts Financial Services's TERN Position: Q2 2026 in Review

Massachusetts Financial Services sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 10,902 shares — an estimated $575K sold.

Massachusetts Financial Services first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $575K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Massachusetts Financial Services reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 10,902 Terns Pharmaceuticals shares in Q2 2026, an estimated $575K.
  • Massachusetts Financial Services first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Massachusetts Financial Services's Terns Pharmaceuticals position peaked at $575K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.